Iron core/shell nanoparticles as magnetic drug carriers: Possible interactions with the vascular compartment

Nanomedicine

Volumn 6, Issue 7, 2011, Pages 1199-1213

  Herrmann, Inge K ^a   Urner, Martin ^b,c   Hasler, Melanie ^b,c   Roth Zgraggen, Birgit ^b,c   Aemisegger, Caroline ^c   Baulig, Werner ^b   Athanassiou, Evagelos K ^a   Regenass, Stephan ^d   Stark, Wendelin J ^a   Beck Schimmer, Beatrice ^b,c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d Department of Internal Medicine   (Switzerland)

Author keywords

carbon; chemotaxis; coagulation; compatibility; complement activation; inflammation; nanomagnets; nanomedicine; phagocytosis; therapy

Indexed keywords

CARBON; CARBON COATED IRON CARBIDE NANOMAGNET; IRON; NANOCARRIER; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD TOXICITY; COMPLEMENT SYSTEM; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; INFLAMMATION; INTRAVASCULAR SPACE; PHAGOCYTE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

BLOOD COAGULATION; BLOOD PLATELETS; CARBON; CELL LINE; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT SYSTEM PROTEINS; ERYTHROCYTES; HEMOLYSIS; HUMANS; IRON; MAGNETS; MATERIALS TESTING; NANOMEDICINE; NANOPARTICLES; PLATELET AGGREGATION; SERUM ALBUMIN;

EID: 80053126245     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.33     Document Type: Article

References (51)

1. Pankhurst QA, Connolly J, SK Jones, Dobson J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D Appl. Phys. 36, R167-R181 (2003).
2. Mornet S, Vasseur S, Grasset F, Duguet E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mater. Chem. 14, 2161-2175 (2004).
3. Ito A, Shinkai M, Honda H, Kobayashi T. Medical application of functionalized magnetic nanoparticles. J. Biosci. Bioeng. 100, 1-11 (2005). (Pubitemid 41573511)
4. Hacliipanayis CG, Bonder MJ, Balakrishanan S, Wang X, Mao H, Hadjipanayis GC. Metallic iron nanoparticles for MRI contrast enhancement and local hyperthermia. Small 4, 1925-1929 (2008).
5. Xu Y, Mahmood M, Li ZR et al. Cobalt nanoparticles coated with graphitic shells as localized radio frequency absorbers for cancer therapy. Nanotechnology 19, 9 (2008).
6. Taylor A, Kraemer K, Hampel S et al. Carbon coated nanomagnets as potential hyperthermia agents. J. Urol. 179, 392-393 (2008).
7. Weber W, Lienhart C, Daoud-El Baba M et al. Magnet-guided transduction of mammalian cells and mice using engineered magnetic lentiviral particles. J. Biotech. 141, 118-122 (2009).
8. Herrmann IK, Grass RN, Stark WJ. High-strength metal nanomagnets for diagnostics and medicine: carbon shells allow long-term stability and reliable linker chemistry. Nanomedicine 4, 787-798 (2009).
9. Lu AH, Salabas EL,Schuth F. Magnetic nanoparticles: Synthesis, protection, functionalization, and application. Angew. Chem. Int. Ed. 46, 1222-1244 (2007).
10. Lu AH, Li WC, Matoussevitch N, Spliethoff B, Bonnemann H, Schuth F. Highly stable carbon-protected cobalt nanoparticles and graphite shells. Chem. Commun. 98-100 (2005).
11. Grass RN, Athanassiou EK, Stark WJ. Covalently functionalized cobalt nanoparticles as a platform for magnetic separations in organic synthesis. Angew. Chem. Int. Ed. 46, 4909-4912 (2007). (Pubitemid 47055956)
12. Studer AM, Limbach LK, Van Duc L et al. Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles. Toxicol. Lett. 197, 169-174 (2010).
13. Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of engineered nanoparticles to human lung epithelial cells: influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Tech. 41, 4158-4163 (2007). (Pubitemid 46903235)
14. 2+influx sensitive to calcium entry inhibitors. Nano Lett. 9, 3312-3317 (2009).
15. Radomski A, Jurasz P, Alonso-Escolano D et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br. J. Pharmacol. 146, 882-893 (2005). (Pubitemid 41622255)
16. Martinez-Barbosa ME, Cammas-Marion S, Bouteiller L, Vauthier C, Ponchel G. PEGylated degradable composite nanoparticles based on mixtures of PEG-b-poly(g-benzyl l-glutamate) and poly(g-benzyl l-glutamate).Bioconj. Chem. 20, 1490-1496 (2009).
17. Hall JB, Dobrovolskaia M, Patri AK, McNeil SE. Characterization of nanoparticles for therapeutics. Nanomedicine (Lond.) 2, 789-803 (2007).
18. Skotland T, Iversen TG, Sandvig K. New metal-based nanoparticles for intravenous use: requirements for clinical success with focus on medical imaging. Nanomedicine (Lond.) 6(6), 730-737 (2010).
19. Dobrovolskaia MA, McNeil SE. Immunological properties of engineered nanomaterials. Nat. Nanotechnol. 2, 469-478 (2007). (Pubitemid 47220069)
20. Dobrovoiskaia MA, Clogston JD, Neun BW, Hall JB, Patri AK, McNeil SE. Method for analysis of nanoparticle hemolytic properties in vitro. Nano Lett. 8, 2180-2187 (2008).
21. Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology 258, 139-147 (2009).
22. Koziara J, Oh J, Akers W, Ferraris S, Mumper R. Blood compatibility of cetyl alcohol/polysorbate-based nanoparticles. Pharm. Res. 22, 1821-1828 (2005). (Pubitemid 41504335)
23. Zahr AS, Davis CA, Pishko MV. Macrophage uptake of core-shell nanoparticles surface modified with poly(ethylene glycol).Langmuir 22, 8178-8185 (2006). (Pubitemid 44412575)
24. Herrmann IK, Grass RN, Mazunin D, Stark WJ. Synthesis and covalent surface functionalization of non-oxidic iron core-shell nanomagnets. Chem. Mater. 21, 3275-3281 (2009).
25. Rossier M, Koehler FM, Athanassiou EK et al. Gold adsorption on the carbon surface of C/Co nanoparticles allows magnetic extraction from extremely diluted aqueous solutions. J. Mater. Chem. 19, 8239-8243 (2009).
26. Durner J. Clinical chemistry: challenges for analytical chemistry and the nanosciences from medicine. Angew. Chem. Int. Ed. 49, 1026-1051 (2010).
27. Sorensen B, Johansen P, Christiansen K, Woelke M, Ingerslev J. Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. J. Thromb. Haemost. 1, 551-558 (2003).
28. Norman ME, Williams P, Illum L. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. Biomaterials 13, 841-849 (1992).
29. Neff SB, Z'Graggen BR, Neff TA et al. Inflammatory response of tracheobronchial epithelial cells to endotoxin. Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L86-L96 (2006).
30. Z'Graggen BR, Tornic J, Muller-Edenborn B, Reyes L, Booy C, Beck-Schimmer B. Acute lung injury: apoptosis in effector and target cells of the upper and lower airway compartment. Clin. Exp. Immunol. 161, 324-331 (2010).
31. Ludwig A, Petersen F, Zahn S et al. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood 90, 4588-4597 (1997). (Pubitemid 27508465)
32. Lambrechts N, Verstraelen S, Lodewyckx H et al. THP-1 monocytes but not macrophages as a potential alternative for CD34+ dendritic cells to identify chemical skin sensitizers. Toxicol. Appl. Pharmacol. 236, 221-230 (2009).
33. Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm. Res. 56, 45-50 (2007). (Pubitemid 46356230)
34. Semple JW, Aslam R, Kim M, Speck ER, Freedman J. Platelet-bound lipopolysaccharide enhances Fc receptor mediated phagocytosis of IgG-opsonized platelets. Blood 109, 4803-4805 (2007). (Pubitemid 46827774)
35. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi CC, Corot C. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest. Radiol. 39, 56-63 (2004). (Pubitemid 38030177)
36. Luciani N, Gazeau F, Wilhelm C. Reactivity of the monocyte/macrophage system to superparamagnetic anionic nanoparticles. J. Mater. Chem. 19, 6373-6380 (2009).
37. Voigtsberger S, Lachmann RA, Leutert AC et al. Sevoflurane ameliorates gas exchange and attenuates lung damage in experimental lipopolysaccharide- induced lung injury. Anesthesiology 111, 1238-1248 (2009).
38. Herrmann IK, Urner M, Koehler FM et al. Blood purification using functionalized core/ shell nanomagnets. Small 6, 1388-1392 (2010).
39. Lang T, Bauters A, Braun SL et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul. Fibrinolysis 16, 301-310 (2005). (Pubitemid 40705054)
40. Cantarero LA, Butler JE, Osborne JW. The adsorptive characteristics of proteins for polystyrene and their significance in solid-phase immunoassays. Anal. Biochem. 105, 375-382 (1980).
41. Owens DE 3rd, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 307, 93-102 (2006). (Pubitemid 41773257)
42. Seely AJE, Naud JF, Campisi G et al. Alteration of chemoattractant receptor expression regulates human neutrophil chemotaxis in vivo. Ann. Surg. 235, 550-559 (2002). (Pubitemid 34258355)
43. Dobrovolskaia MA, Aggarwal P, Hall JB, McNeil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm. 5, 487-495 (2008).
44. Ding, L, Stilwell, J, Zhang, T et al. Molecular characterization of the cytotoxic mechanism of multiwall carbon nanotubes and nano-onions on human skin fibroblast. Nano. Lett. 5, 2448-2464 (2005). (Pubitemid 43090840)
45. Schildberger A, Rossmanith E, Weber V, Falkenhagen D. Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model. Innate Immun. 16, 278-287 (2010).
46. Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Tech. 40, 4353-4359 (2006). (Pubitemid 44092367)
47. Limbach LK, Li YC, Grass RN et al. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Tech. 39, 9370-9376 (2005). (Pubitemid 41741229)
48. Bartneck M, Keul HA, Singh S et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano 4, 3073-3086 (2010).
49. Bartneck M, Keul HA, Zwadlo-Klarwasser G, Groll JR. Phagocytosis independent extracellular nanoparticle clearance by human immune cells. Nano Lett. 10, 59-63 (2009).
50. Wozniak, MJ, Wozniak P, Bystrzejewski M et al. Magnetic nanoparticles of Fe and Nd-Fe-B alloy encapsulated in carbon shells for drug delivery systems: study of the structure and interaction with the living cells. J. Alloys Compd 423, 87-91 (2006). (Pubitemid 44397476)
51. Brunner TJ, Wick P, Manser P et al. In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Tech. 40, 4374-4381 (2006). (Pubitemid 44092369)